Cargando…
Wenyang Lishui Decoction Ameliorates Podocyte Injury in Membranous Nephropathy Rat and Cell Models by Regulating p53 and Bcl-2
Wenyang Lishui decoction (WYD) has been frequently used to treat patients with membranous nephropathy (MN) in China. Our previous study in vitro showed that WYD aqueous extract could alleviate F-actin reorganization of podocytes induced by serum from idiopathic membranous nephropathy (IMN) patients....
Autores principales: | Lu, Huan, Luo, Yuezhong, Su, Baolin, Tang, Shuifu, Chen, Gangyi, Zhang, Licai, Song, Chao, Wang, Chao, Tu, Haitao, Wu, Xinbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243012/ https://www.ncbi.nlm.nih.gov/pubmed/32454867 http://dx.doi.org/10.1155/2020/6813760 |
Ejemplares similares
-
Laxative effect of Wenyang Yiqi Decoction on loperamide-induced astriction model mice
por: Su, Yugang, et al.
Publicado: (2023) -
“Yiqi Huayu, Wenyang Lishui” Prescription (YHWLP) Improves the Symptoms of Chronic Obstructive Pulmonary Disease-Induced Chronic Pulmonary Heart Disease by Inhibiting the RhoA/ROCK Signaling Pathway
por: Huang, Hui, et al.
Publicado: (2021) -
Wenyang Jieyu Decoction Alleviates Depressive Behavior in the Rat Model of Depression via Regulation of the Intestinal Microbiota
por: Feng, Zhenyu, et al.
Publicado: (2020) -
Wuzang Wenyang Huayu decoction regulates differentially expressed transcripts in the rats' hippocampus after cerebral hypoperfusion
por: Xia, Meng, et al.
Publicado: (2019) -
Integrated network pharmacology and proteomics to reveal the cognitive improvement effect of Wuzang Wenyang Huayu decoction on vascular dementia
por: Sun, Yuhao, et al.
Publicado: (2022)